1. Home
  2. CLRO vs PHIO Comparison

CLRO vs PHIO Comparison

Compare CLRO & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ClearOne Inc. (DE)

CLRO

ClearOne Inc. (DE)

N/A

Current Price

$5.35

Market Cap

10.3M

Sector

Technology

ML Signal

N/A

Logo Phio Pharmaceuticals Corp.

PHIO

Phio Pharmaceuticals Corp.

HOLD

Current Price

$1.07

Market Cap

12.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLRO
PHIO
Founded
1983
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3M
12.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CLRO
PHIO
Price
$5.35
$1.07
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$10.67
AVG Volume (30 Days)
13.1K
374.1K
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,386,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
174.10
N/A
52 Week Low
$3.83
$0.97
52 Week High
$21.00
$9.79

Technical Indicators

Market Signals
Indicator
CLRO
PHIO
Relative Strength Index (RSI) 50.76 29.23
Support Level $5.25 $1.04
Resistance Level $5.52 $1.20
Average True Range (ATR) 0.29 0.09
MACD 0.01 0.01
Stochastic Oscillator 20.29 5.18

Price Performance

Historical Comparison
CLRO
PHIO

About CLRO ClearOne Inc. (DE)

ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

Share on Social Networks: